Outset Medical, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-81.7M | $-128.0M | $-172.8M | $-163.0M | $-131.9M | $-121.5M | $-68.3M | $-49.8M |
| Depreciation & Amortization | $4.3M | $5.7M | $5.8M | $5.2M | $5.2M | $3.2M | $1.5M | $1.1M |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $15.6M | $29.4M | $38.6M | $27.2M | $17.4M | $21.4M | $883.0K | $788.0K |
| Net Cash from Operating Activities | $-46.3M | $-116.3M | $-131.4M | $-145.7M | $-130.3M | $-99.0M | $-70.3M | $-46.4M |
| Investing Activities | ||||||||
| Capital Expenditures | $798.0K | $912.0K | $3.4M | $8.3M | $3.1M | $9.1M | $3.3M | $1.8M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-97.7M | $103.9M | $83.0M | $-66.3M | $-142.5M | $3.9M | $74.3M | $-68.8M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $55.5M | $67.9M | $43.7M | $72.9M | $160.1M | $385.7M | $249.0K | $134.9M |
| Net Change in Cash | $-88.5M | $55.5M | $-4.7M | $-139.1M | $-112.6M | $290.6M | $4.3M | $19.7M |
| Free Cash Flow | $-47.1M | $-117.2M | $-134.8M | $-154.1M | $-133.4M | $-108.1M | $-73.6M | $-48.2M |